Some studies have shown higher levels of TNF-beta in the peripheral blood of meningioma patients compared to normal individuals (Boyle-Walsh et al., 1996), which may be associated with increased tumor invasiveness, higher risk of recurrence, and enhanced resistance to treatment. This evidence concerns the gene LTA and neoplasm.